Sfoglia per Autore
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis
2017-01-01 Roviello, Giandomenico; Corona, Silvia Paola; Generali, Daniele
Isolated testicular metastasis from prostate cancer
2017-01-01 Bonetta, Alberto; Generali, Daniele; Corona, Silvia Paola; Cancarini, Gianni; Brenna, Sarahgrazia; Pacifico, Chiara; Roviello, Giandomenico
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer
2017-01-01 Roviello, Giandomenico; Corona, Silvia Paola; Bonetta, Alberto; Cappelletti, Maria Rosa; Generali, Daniele
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma
2017-01-01 Sobhani, Navid; Corona, Silvia P; Zanconati, Fabrizio; Generali, Daniele
CDK4/6 inhibitors in HER2-positive breast cancer
2017-01-01 Corona, Silvia Paola; Ravelli, Angelo; Cretella, Daniele; Cappelletti, Maria Rosa; Zanotti, Laura; Dester, Martina; Gobbi, Angela; Petronini, Pier Giorgio; Generali, Daniele
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer
2017-01-01 Milani, Manuela; Venturini, Sergio; Bonardi, Simone; Allevi, Giovanni; Strina, Carla; Cappelletti, Maria Rosa; Corona, Silvia Paola; Aguggini, Sergio; Bottini, Alberto; Berruti, Alfredo; Jubb, Adrian; Campo, Leticia; Harris, Adrian L.; Gatter, Kevin; Fox, Stephen B.; Generali, Daniele; Roviello, Giandomenico
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma
2017-01-01 Sobhani, Navid; Roviello, Giandomenico; Corona, S. P.; Ianza, Anna; Zanconati, Fabrizio; Generali, Daniele
Advances in systemic therapy for malignant mesothelioma: Future perspectives
2017-01-01 Sobhani, Navid; Corona, Silvia Paola; Bonazza, Deborah; Ianza, Anna; Pivetta, Tania; Roviello, Giandomenico; Cortale, Maurizio; Guglielmi, Alessandra; Zanconati, Fabrizio; Generali, Daniele
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?
2017-01-01 Corona, Silvia Paola; Roviello, Giandomenico; Strina, Carla; Milani, Manuela; Allevi, Giovanni; Aguggini, Sergio; Zanoni, Daniele; Generali, Daniele
Advances in systemic therapy for metastatic breast cancer: future perspectives
2017-01-01 Corona, S. P.; Sobhani, Navid; Ianza, Anna; Roviello, Giandomenico; Mustacchi, Giorgio; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele
Lenvatinib for the treatment of renal cell carcinoma
2018-01-01 Roviello, G.; Corona, S.; Bozza, G.; Aieta, M.; Generali, D.; Rodriquenz, M. G.; Mileo, A. M.; Imperatori, M.; Ianza, A.; Conca, R.; Sobhani, N.
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer
2018-01-01 Roviello, Giandomenico; Corona, Silvia Paola; Multari, Andrea Giovanni; Paganini, Giovanni; Chiriacò, Giorgio; Conca, Raffaele; Petrioli, Roberto; Generali, Daniele; Rosellini, Pietro; Aieta, Michele
Abemaciclib: A CDK4/6 inhibitor for the treatment of HR+/HEeR2- advanced breast cancer
2018-01-01 Corona, Silvia Paola; Generali, Daniele
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR
2018-01-01 Generali, Daniele; Corona, Silvia Paola; Pusztai, Lajos; Rouzier, Roman; Allevi, Giovanni; Aguggini, Sergio; Milani, Manuela; Strina, Carla; Frati, Albane
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis
2018-01-01 Sobhani, Navid; Roviello, Giandomenico; Corona, Silvia; Scaltriti, Maurizio; Ianza, Anna; Bortul, Marina; Zanconati, Fabrizio; Generali, Daniele
Efficacy of extended aromatase inhibitors for hormone-receptor–positive breast cancer: A literature-based meta-analysis of randomized trials
2019-01-01 Corona, S.; Roviello, G.; Strina, C.; Milani, M.; Madaro, S.; Zanoni, D.; Allevi, G.; Aguggini, S.; Cappelletti, M. R.; Francaviglia, M.; Azzini, C.; Cocconi, A.; Sirico, M.; Bortul, M.; Zanconati, F.; Giudici, F.; Rosellini, P.; Meani, F.; Pagani, O.; Generali, D.
Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies before and after Chemotherapy
2019-01-01 Roviello, G.; Corona, S.; Aieta, M.; Roudi, R.
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel
2019-01-01 Roviello, G.; Corona, S.; Multari, A. G.; Petrioli, R.; Rosellini, P.; Aieta, M.
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma
2019-01-01 Sobhani, N; Roviello, G; Pivetta, T; Ianza, A; Bonazza, D; Zanconati, F; Giudici, F; Bottin, C; Corona, Sp; Guglielmi, A; Rizzardi, C; Milione, M; Cortale, M; Confalonieri, M; Generali, D.
Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?
2019-01-01 Roviello, G.; Corona, S.; Nesi, G.; Mini, E.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile